Description
Advances in recombinant antibodies have impact on a range of therapy areas, such as oncology, CNS, infectious and inflammatory diseases. With an expert line-up of speakers, 3rd Annual Recombinant Antibodies Conference is an ideal forum for industry and academia alike. This 2-day event will explore novel applications of antibodies, recent advances in antibody engineering and the latest clinical developments.
By attending this conference you will:
Examine future trends in global antibody development
Hear the latest strategies for protecting antibodies and receive relevant regulatory information
Reduce immunogenicity risk by overcoming immune reactions to improve clinical applications of antibody therapeutics
Explore recent developments in antibody therapy against infl ammatory/ autoimmune diseases
Improve clinical study design
Hear case studies on developments of recombinant antibodies as cancer therapeutics
